| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $1.09 (Beat by $0.04) |
| EPS GAAP Actual | $1.09 (Beat by $0.04) |
| Revenue Actual | $36.381B |
| Revenue Surprise | Beat by $36381M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.2402 |
| EPS GAAP Estimate | $1.2402 |
| Revenue Estimate | $33.651766799B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | 6.55 | 7.07 | 6.33172 | 6.83492 | 1 |
| Dec 2029 | 5.505 | 8.41 | 5.43945 | 5.64131 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.87 | 0.87 | 36.381B | 1.92% | 36381M |
| FQ3 2025 (Sep 2025) | 1.17 | 1.17 | 33.821B | 1.54% | 33821M |
| FQ2 2025 (Jun 2025) | 1.18 | 1.18 | 34.504B | 4.95% | 34504M |
| FQ1 2025 (Mar 2025) | 1.89 | 1.89 | 33.485B | 1.51% | 33485M |
| FQ4 2024 (Dec 2024) | 1.19 | 1.19 | 35.681B | 1.54% | 35681M |
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 33.3B | -0.11% | 33300M |
| FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 32.796B | 0.61% | 32796M |
| FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 32.981B | 0.21% | 32981M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.2402
Consensus Revenue Estimates
33.651766799B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.18 | -- | 1.15734 | 1.19441 | 4 |
| FQ3 2027 (Sep 2027) | 1.33 | -- | 1.30446 | 1.34625 | 3 |
| FQ2 2027 (Jun 2027) | 1.28 | -- | 1.25542 | 1.29564 | 4 |
| FQ1 2027 (Mar 2027) | 1.26 | -- | 1.2358 | 1.27539 | 3 |
| FQ4 2026 (Dec 2026) | 1.16556 | 25.36 | 1.14317 | 1.1798 | 4 |
| FQ3 2026 (Sep 2026) | 1.23856 | 5.54 | 1.21477 | 1.25369 | 3 |
| FQ2 2026 (Jun 2026) | 1.24189 | 4.98 | 1.21804 | 1.25706 | 4 |
| FQ1 2026 (Mar 2026) | 1.2402 | -52.39 | 1.2402 | 1.2402 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 37.4B | -- | 36.85B | 37.75B | 3 |
| FQ3 2027 (Sep 2027) | 34.53B | -- | 34.02B | 34.86B | 3 |
| FQ2 2027 (Jun 2027) | 33.84B | -- | 33.34B | 34.15B | 3 |
| FQ1 2027 (Mar 2027) | 34.17B | -- | 33.66B | 34.49B | 3 |
| FQ4 2026 (Dec 2026) | 36.96B | 1.57 | 36.42B | 37.31B | 3 |
| FQ3 2026 (Sep 2026) | 34.81B | 2.84 | 34.3B | 35.14B | 3 |
| FQ2 2026 (Jun 2026) | 34.93B | 1.22 | 34.42B | 35.26B | 3 |
| FQ1 2026 (Mar 2026) | 33.65B | 0.5 | 33.65B | 33.65B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.87 | 0.87 | 100% | |
| FQ3 2025 (Sep 2025) | 1.17 | 1.17 | 100% | |
| FQ2 2025 (Jun 2025) | 1.18 | 1.18 | 100% | |
| FQ1 2025 (Mar 2025) | 1.89 | 1.89 | 100% | |
| FQ4 2024 (Dec 2024) | 1.19 | 1.19 | 100% | |
| FQ3 2024 (Sep 2024) | 0.78 | 0.78 | 100% | |
| FQ2 2024 (Jun 2024) | 1.09 | 1.09 | 100% | |
| FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $36.38B | $36381M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $33.82B | $33821M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $34.5B | $34504M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $33.49B | $33485M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $35.68B | $35681M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $33.3B | $33300M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $32.8B | $32796M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $32.98B | $32981M | 100% |